share_log

Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $130

Truist Securities Reiterates Buy on Tenet Healthcare, Raises Price Target to $130

信託證券重申買入Tenet Healthcare,將目標股價上調至130美元
Benzinga ·  05/01 08:57

Truist Securities analyst David Macdonald reiterates Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $120 to $130.

Truist Securities分析師戴維·麥克唐納重申了Tenet Healthcare(紐約證券交易所代碼:THC)的買入並將目標股價從120美元上調至130美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論